Frontiers in Oncology (Jan 2025)

Advances and current concepts on Eph receptors and ephrins in upper digestive tract cancers

  • Luccas Lavareze,
  • Luccas Lavareze,
  • Talita de Carvalho Kimura,
  • Talita de Carvalho Kimura,
  • João Figueira Scarini,
  • João Figueira Scarini,
  • Reydson Alcides de Lima-Souza,
  • Reydson Alcides de Lima-Souza,
  • Moisés Willian Aparecido Gonçalves,
  • Moisés Willian Aparecido Gonçalves,
  • Raisa Sales de Sá,
  • Raisa Sales de Sá,
  • Iara Gonçalves Aquino,
  • Iara Gonçalves Aquino,
  • Patricia Maria Fernandes,
  • Fernanda Cristina Poscai Ribeiro,
  • Albina Altemani,
  • Fernanda Viviane Mariano,
  • Gary Chris Fillmore,
  • Erika Said Abu Egal,
  • Erika Said Abu Egal

DOI
https://doi.org/10.3389/fonc.2024.1520306
Journal volume & issue
Vol. 14

Abstract

Read online

Erythropoietin-producing hepatocellular (Eph) receptors comprise the largest group of surface receptors and are responsible for cellular signals. Eph/ephrin signaling has been identified to play a role in key cancer development and progression processes, especially in the upper gastrointestinal tract. The Eph/ephrin system has been described as a tumor suppressor in duodenal cancer, while in esophageal, gastric, hepatic, and pancreatic cancer, the system has been related to tumor progression. For their significant role in developing a wide range of malignancies, Eph receptors and their ligands have proven to be an important target for new anticancer therapies. In this review, we present an overview of the literature and highlight evidence supporting the role of the Eph/ephrin system in upper digestive tract cancers. In addition, we discuss molecular findings that represent promising therapeutic targets for these cancers.

Keywords